The Latest Breaking News from FDA

Musk’s brain implants company, Neuralink, is already the subject of a federal investigation.

With the FORMULA Act soon to expire, the U.S. baby formula market is about to return to the conditions that left it so vulnerable to a shortage in the first place.

You can't patent naturally-occurring molecules like psilocybin. That's led to a rush to find a synthetic blend

Emergent BioSolutions has applied to the Food and Drug Administration to sell the opioid overdose-reversal drug over the counter. Addiction experts say it may be a key step to lower fentanyl deaths.

The U.S. Food and Drug Administration approved Mirati Therapeutics Inc's lung cancer drug adagrasib, the company said on Monday, sending its shares up more than 8% in extended trading.

Naloxone could be available without a prescription by spring.

About 900 civil servants on fast stream being balloted, with 81% backing industrial action at consultative stage

Aspartame, an artificial sweetener included in approximately 5,000 diet goods and beverages, has been linked by Florida State University College of Medicine researchers to anxiety-like behaviour in mice. Read on for details:

A new generation of FDA-approved diabetes drugs that can also help patients lose weight has prompted enthusiasm from doctors and a firestorm of demand among patients so strong it's led to shortages.

Studies show the products may double the risk of uterine cancer, but tradition, societal pressure and personal taste create obstacles to change

Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with COVID-19 from being hospitalized or dying, and it may even reduce the risk of developing long COVID. But the government plans to stop footing the bill…